Ron Rosenstraus
@Eversept Partners, Lp
Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.
Assets under management
The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GSKGsk Plc
| 11.37% | $165.859M 4.057M shares@ $40.88 avg price | Increased 16.99% |
QQQInvesco Qqq Tr
| 8.35% | $121.822M↓ Put 249,600 shares@ $488.07 avg price | Decreased -12.6% |
NTRANatera Inc
| 7.57% | $110.471M 870,193 shares@ $126.95 avg price | Decreased -25.84% |
VERAVera Therapeutics Inc
| 6.21% | $90.617M 2.05M shares@ $44.2 avg price | Increased 0.34% |
INSMInsmed Inc
| 5.45% | $79.526M 1.089M shares@ $73.0 avg price | Decreased -5.72% |
SNDXSyndax Pharmaceuticals Inc
| 5.42% | $79.027M 4.105M shares@ $19.25 avg price | Increased 13.61% |
RVTYRevvity Inc
| 4.12% | $60.003M 469,692 shares@ $127.75 avg price | Increased 4.02% |
INSPInspire Med Sys Inc
| 4% | $58.307M 276,270 shares@ $211.06 avg price | Decreased -48.16% |
TEVATeva Pharmaceutical Inds Ltd
| 4% | $58.288M 3.235M shares@ $18.03 avg price | Decreased -31.47% |
CYHCommunity Health Sys Inc New
| 3.65% | $53.273M 8.776M shares@ $6.08 avg price | Increased 9.2% |